Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pancreas; Insulinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)WithdrawnNCT04915144
What this trial is testing

177Lu-DOTATOC for the Treatment of Patients With Somatostatin Receptor Positive NETs

Who this might be right for
Neuroendocrine TumorsCarcinoid TumorPulmonary Carcinoid Tumor+4 more
British Columbia Cancer Agency
Testing effectiveness (Phase 2)Study completedNCT00131911
What this trial is testing

Sorafenib Tosylate in Treating Patients With Progressive Metastatic Neuroendocrine Tumors

Who this might be right for
GastrinomaGlucagonomaInsulinoma+7 more
National Cancer Institute (NCI) 93
Early research (Phase 1)WithdrawnNCT02831179
What this trial is testing

Veliparib, Capecitabine, and Temozolomide in Patients With Advanced, Metastatic, and Recurrent Neuroendocrine Tumor

Who this might be right for
Functional Pancreatic Neuroendocrine TumorMalignant SomatostatinomaMerkel Cell Carcinoma+26 more
Vanderbilt-Ingram Cancer Center
Testing effectiveness (Phase 2)Ended earlyNCT00084461
What this trial is testing

Romidepsin in Treating Patients With Locally Advanced or Metastatic Neuroendocrine Tumors

Who this might be right for
GastrinomaGlucagonomaInsulinoma+7 more
National Cancer Institute (NCI) 25
Not applicableEnded earlyNCT04452396
What this trial is testing

CGM (Continuous Glucose Monitoring) Use in Diagnosis of Spontaneous and Reactive Hypoglycaemia

Who this might be right for
Hypoglycemia, ReactiveHypoglycaemia NightHypoglycemia Non-Diabetic+7 more
Barts & The London NHS Trust 7
Not applicableStudy completedNCT00937079
What this trial is testing

Whole Body 111In-exendin-4 Imaging Study in Insulinoma Patients

Who this might be right for
HyperinsulinismHypoglycemiaInsulinoma
University Hospital, Basel, Switzerland 30
Testing effectiveness (Phase 2)Study completedNCT00454363
What this trial is testing

Pazopanib Hydrochloride in Treating Patients With Advanced Neuroendocrine Cancer

Who this might be right for
Gastrin-Producing Neuroendocrine TumorLung Carcinoid TumorMetastatic Digestive System Neuroendocrine Tumor G1+8 more
National Cancer Institute (NCI) 52
Testing effectiveness (Phase 2)Ended earlyNCT02273752
What this trial is testing

Pharmacokinetically Guided Everolimus in Patients With Breast Cancer, Pancreatic Neuroendocrine Tumors, or Kidney Cancer

Who this might be right for
Estrogen Receptor-positive Breast CancerGastrinomaGlucagonoma+16 more
Emory University 2
Large-scale testing (Phase 3)Study completedNCT00538850
What this trial is testing

Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain

Who this might be right for
Cancer
INSYS Therapeutics Inc 130
Testing effectiveness (Phase 2)Study completedNCT00416767
What this trial is testing

Combination Chemotherapy as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Neuroendocrine Tumors of the Duodenum or Pancreas That Cannot Be Removed By Surgery

Who this might be right for
Gastrointestinal Carcinoid TumorIslet Cell TumorNeoplastic Syndrome
Federation Francophone de Cancerologie Digestive 20
Large-scale testing (Phase 3)Study completedNCT00325104
What this trial is testing

Cinacalcet to Treat Familial Primary Hyperparathyroidism

Who this might be right for
HypercalcemiaFamilial Primary Hyperparathyroidism
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 25
Testing effectiveness (Phase 2)Study completedNCT00427349
What this trial is testing

AMG 706 and Octreotide in Treating Patients With Low-Grade Neuroendocrine Tumors

Who this might be right for
Gastrointestinal Carcinoid TumorIslet Cell TumorNeoplastic Syndrome
Eastern Cooperative Oncology Group 46
Early research (Phase 1)Ended earlyNCT00002947
What this trial is testing

Indium In 111 Pentetreotide in Treating Patients With Refractory Cancer

Who this might be right for
Brain and Central Nervous System TumorsChildhood Langerhans Cell HistiocytosisGastrointestinal Carcinoid Tumor+9 more
Yale University 35
Not applicableStudy completedNCT02127541
What this trial is testing

New Imaging Procedure for the Localisation of Insulinoma

Who this might be right for
Endogenous Hyperinsulinaemic Hypoglycaemia
University Hospital, Basel, Switzerland 52
Very early researchUnknownNCT02560376
What this trial is testing

68Ga-NOTA-exendin-4 PET/CT for the Localization of Insulinoma and Diagnosis of Nesidioblastosis

Who this might be right for
InsulinomaNesidioblastosis
Peking Union Medical College Hospital 100
Not applicableStudy completedNCT04741152
What this trial is testing

Blinded Resection in Case of the Pancreatic Insulinoma

Who this might be right for
Insulinoma; Pancreas
Vishnevsky Center of Surgery 197
Testing effectiveness (Phase 2)WithdrawnNCT03053284
What this trial is testing

Pasireotide in Hyperinsulinemic Hypoglycemia

Who this might be right for
Congenital HyperinsulinismInsulinomaHyperinsulinism
Montefiore Medical Center
Testing effectiveness (Phase 2)Study completedNCT00017199
What this trial is testing

PS-341 in Treating Patients With Metastatic Neuroendocrine Tumors

Who this might be right for
Gastrointestinal Carcinoid TumorIslet Cell Tumor
Ohio State University Comprehensive Cancer Center
Not applicableActive Not RecruitingNCT05735912
What this trial is testing

EUS-RFA Versus Surgery for Pancreatic Insulinoma (ERASIN-RCT)

Who this might be right for
Pancreatic Insulinoma
Azienda Ospedaliera Universitaria Integrata Verona 60
Not applicableStudy completedNCT07340437
What this trial is testing

Clinical Study of 18F-Exendin-4 in Insulinoma

Who this might be right for
Insulinoma
Sichuan Provincial People's Hospital 20
Next Page